Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients
@article{ACTR10704, author = {Klaus Podar}, title = {Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients}, journal = {AME Clinical Trials Review}, volume = {0}, number = {0}, year = {2025}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10704} }